The effect of a subnormal vitamin B-6 status on homocysteine metabolism

Journal of Clinical Investigation

Volumn 98, Issue 1, 1996, Pages 177-184

  Ubbink, Johan B ^a   Van Der Merwe, Annatjie ^a   Delport, Rhena ^a   Allen, Robert H ^b   Stabler, Sally P ^b   Riezler, Reiner ^c   Vermaak, W J Hayward ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF COLORADO   (United States)

^c Severimed   (Germany)

Author keywords

coronary heart disease; cystathionine; folate; methionine; vitamin B 12

Indexed keywords

CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; THEOPHYLLINE;

AMINO ACID METABOLISM; ARTICLE; ASTHMA; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG SULFATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LOADING TEST; MALE; METHYLATION; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; VITAMIN INTAKE;

EID: 0030035427     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118763     Document Type: Article

References (52)

1. Clarke, R., L. Daly, K. Robinson, E. Naughten, S. Cahalane, B. Fowler, and I. Graham. 1991. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324:1149-1155.
2. Murphy-Chutorian, D.R., M.P. Wexman, A.J. Grieco, J.A. Heininger, E. Glassman, G. Gaull, F. Feit, K. Wexman, and A.C. Fox. 1985. Methionine intolerance: a possible risk factor for coronary artery disease. J. Am. Coll. Cardiol. 6: 725-730.
3. Malinow, M.R., J. Nieto, M. Szklo, L.E. Chambless, and G. Bond. 1993. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. Circulation. 87:1107-1113.
4. Wu, L.L., J. Wu, S.C. Hunt, B.C. James, G.M. Vincent, R.R. Williams, and P.N. Hopkins. 1994. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin. Chem. 40:552-561.
5. Selhub, J., P.F. Jacques, A.G. Bostom, R.B. D'Agostino, P.W.F. Wilson, A.J. Belanger, D.H. O'Leary, P.A. Wolf, E.J. Schaefer, and I.H. Rosenberg. 1995. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332:286-291.
6. Glueck, C.J., P. Show, J.E. Lang, T. Tracey, L. Sieve-Smith, and Y. Wang. 1995. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am. J. Cardiol. 75:132-136.
7. Steegers-Theunissen, R.P.M., G.H.J. Boers, F.J.M. Trijbels, J.D. Finkelstein, H.J. Blom, C.M.G. Thomas, G.F. Borm, M.G.A.J. Wouters, and T.K.A.B. Eskes. 1994. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metab. Clin. Exp. 43:1475-1480.
8. Mills, J.L., J.M. McPartlin, P.N. Kirke, Y.J. Lee, M.R. Conley, D.G. Weir, and J.M. Scott. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 345:149-151.
9. Gibson, J.B., N.A.J. Carson, and D.W. Neill. 1964. Pathological findings in homocystinuria. J. Clin. Pathol. 17:427-437.
10. McCully, K.S. 1969. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56:111-128.
11. Kanwar, Y.S., J.R. Manaligod, and P.W.K. Wong. 1976. Morphologic studies in a patient with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediatr. Res. 10:598-609.
12. Van der Put, N.M.J., R.P.M. Steegers-Theunissen, P. Frosst, F.J.M. Trijbels, T.K.A.B. Eskes, L.P. van den Heuvel, E.C.M. Mariman, M. Den Heyer, R. Rozen, and H.J. Blom. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1070-1071.
13. Boers, G.H.J., A.G.H. Smals, F.J.M. Trijbels, B. Fowler, J.A.J.M. Bakkeren, H.C. Schoonderwaldt, W.J. Kleijer, and P.W.C. Kloppenborg. 1985. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N. Engl. J. Med. 313:709-715.
14. Kang, S.S., P.W.K. Wong, A. Susmano, J. Sora, M. Norusis, and N. Ruggie. 1991. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am. J. Hum. Genet. 48:536-545.
15. Kang, S.S., E.L. Passen, N. Ruggie, P.W.K. Wong, and H. Sora. 1993. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 88:1463-1469.
16. Stipanuk, M.H. 1986. Metabolism of sulfur-containing amino acids. Ann. Rev. Nutr. 6:179-209.
17. Ubbink, J.B., W.J.H. Vermaak, A. Van der Merwe, and P.J. Becker. 1993. Vitamin B-12, vitamin B-6 and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin. Nutr. 57:47-53.
18. Selhub, J., P.F. Jacques, P.W.F. Wilson, D. Rush, and I.H. Rosenberg. 1993. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. Med. Assoc. 270:2693-2698.
19. Pancharuniti, N., C.A. Lewis, H.E. Sauberlich, L.L. Perkins, R.C.P. Go, J.O. Ahvarez, M. Maculuso, R.T. Acton, R.B. Copeland, A.L. Cousins, et al. 1994. Plasma homocyst(e)ine, folate, and vitamin B12 concentrations and risk for early-onset coronary artery disease. Am. J. Clin. Nutr. 59:940-948.
20. Hopkins, P.N., L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams. 1995. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 15:1314-1320.
21. Kang, S., P.W.K. Wong, and M. Norusis. 1987. Homocysteinemia due to folate deficiency. Metab. Clin. Exp. 36:458-462.
22. Stabler, S.P., P.D. Maecell, E.R. Podell, R.H. Allen, G. Savage, and J. Lindenbaum. 1988. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J. Clin. Invest. 81:466-474.
23. Savage, D.G., J. Lindenbaum, S.P. Stabler, and R.H. Allen. 1994. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am. J. Med. 96:239-246.
24. Kang, S., J. Zhou, P.W.K. Wong, J. Kowalisyn, and G. Strokosch. 1988. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 43:414-421.
25. Kang, S.S., P.W.K. Wong, H.G. Otto Bock, A. Horwitz, and A. Grix. 1991. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am. J. Hum. Genet. 48:546-551.
26. Brattström, L., B. Israelsson, F. Lingarde, and B. Hultberg. 1988. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. Metab. Clin. Exp. 37:175-178.
27. Boers, G.H.J., B. Fowler, A.G.H. Smals, F.J.M. Trijbels, A.I. Leermakers, W.J. Kleijer, and P.W.C. Kloppenborg. 1985. Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum. Genet. 69:164-169.
28. Wilcken, D.E.L., S.G. Reddy, and V.J. Gupta. 1983. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. Metab. Clin. Exp. 32:363-370.
29. Miller, J.W., J.D. Ribaya-Mercado, R.M. Russell, D.C. Shepard, F.D. Morrow, E.F. Cochary, J.A. Sadowski, S.N. Gershoff, and J. Selhub. 1992. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am. J. Clin. Nutr. 55:1154-1160.
30. Ubbink, J.B., W.J.H. Vermaak, A. Van der Merwe, P.J. Becker, R. Delport, and H.C. Potgieter. 1994. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124:1927-1933.
31. Brattström, L., B. Israelsson, B. Norrving, D. Bergqvist, J. Thorne, B. Hultberg, and A. Hamfelt. 1990. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Atherosclerosis. 81:51-60.
32. Dudman, N.P.B., D.E.L. Wilcken, J. Wang, J.F. Lynch, D. Macey, and P. Lundberg. 1993. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler. Thromb. 13:1253-1260.
33. Selhub, J., and J.W. Miller. 1992. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 55:131-138.
34. Park, Y.K., and H. Linkswiler. 1970. Effect of vitamin B6 depletion in adult man on the excretion of cystathionine and other methionine metabolites. J. Nutr. 100:110-116.
35. Shin, H.K., and H.M. Linkswiler. 1974. Tryptophan and methionine metabolism of adult females as affected by vitamin B-6 deficiency. J. Nutr. 104: 1348-1355.
36. Miller, J.W., M.R. Nadeau, D. Smith, and J. Selhub. 1994. Vitamin B-6 deficiency versus folate deficiency: comparison of responses to methionine loading in rats. Am. J. Clin. Nutr. 59:1033-1039.
37. Stabler, S.P., and R.H. Allen. 1994. Elevations of serum cystathionine and homocysteine in vitamin B-6, folate and cobalamin deficient rats. Blood. 84(Suppl. 1):118a. (Abstr.)
38. Ubbink, J.B., R. Delport, P.J. Becker, and S. Bissbort. 1989. Evidence of a theophylline-induced vitamin B6 deficiency caused by noncompetitive inhibition of pyridoxal kinase. J. Lab. Clin. Med. 113:15-22.
39. Ubbink, J.B., S. Bissbort, and W.J.H. Vermaak. 1990. Inhibition of pyridoxal kinase by methylxanthines. Enzyme. 43:72-79.
40. Ubbink, J.B., R. Delport, S. Bissbort, W.J.H. Vermaak, and P.J. Becker. 1990. Relationship between vitamin B-6 status and elevated pyridoxal kinase levels induced by theophylline therapy in humans. J. Nutr. 120:1352-1359.
41. Ubbink, J.B., W.J. Serfontein, and L.S. de Villiers. 1985. Stability of pyridoxal-5-phosphate semicarbazone: application in plasma vitamin B-6 analysis and population surveys of vitamin B-6 nutritional status. J. Chromatogr. 342: 277-284.
42. Araki, A., and Y. Sako. 1987. Determination of free and total homocysteine in human plasma by HPLC with fluorescence detection. J. Chromatogr. 422:43-52.
43. Ubbink, J.B., W.J.H. Vermaak, and S. Bissbort. 1991. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565:441-446.
44. Blanchard, J., S. Harvey, and W.J. Morgan. 1990. A rapid and specific high-performance liquid chromatographic assay for theophylline in biological fluids. J. Chromatogr. Sci. 28:303-306.
45. Allen, R.H., S.P. Stabler, D.G. Savage, and J. Lindenbaum. 1993. Metabolic abnormalities in cobalamin (vitamin B-12) and folate deficiency. FASEB (Fed. Am. Soc. Exp. Biol.) J. 7:1344-1352.
46. Conover, W.J. 1971. Practical Non-Parametric Statistics. John Wiley & Sons, New York.
47. Brattström, L.E., B. Israelsson, J.O. Jeppson, and B.L. Hultberg. 1988. Folic acid: an innocuous means to reduce plasma homocysteine. Scand. J. Clin. Lab. Invest. 48:215-221.
48. Andersson, A., L. Brattström, and B. Israelsson. 1992. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur. J. Clin. Invest. 22:79-87.
49. Bostom, A.G., P.F. Jacques, M.R. Nadeau, R.R. Williams, R.C. Ellison, and J. Selhub. 1995. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis. 116:147-151.
50. Binkley, F., G.M. Christensen, and W.N. Jensen 1952. Pyridoxine and the transfer of sulfur. J. Biol. Chem. 194:109-113.
51. Ubbink, J.B., W.J.H. Vermaak, A. van der Merwe, P.J. Becker, and H. Potgieter. 1995. Effective homocysteine metabolism may protect South African Blacks against coronary heart disease. Am. J. Clin. Nutr. 62:802-808.
52. Allen, R.H., S.P. Stabler, D.G. Savage, and J. Lindenbaum. 1993. Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metab. Clin. Exp. 42:978-988.